Author: admin

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Minister for the Cabinet Office, how many people were diagnosed with primary refractory acute megakaryoblastic leukaemia in each of the last five years.

Mr Rob Wilson

The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, what his Department’s policy is on the provision of precautionary mastectomies for women who have not been diagnosed with breast cancer.

Jane Ellison

The National Institute for Health and Care Excellence published guidance to the National Health Service on bilateral risk-reducing mastectomy in its clinical guideline, Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (June 2013). This is available at:

www.nice.org.uk/guidance/cg164/chapter/1-recommendations

“

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, how many people were diagnosed with (a) anxiety and (b) depression in each of the last five years.

Alistair Burt

Data published by the Health and Social Care Information Centre on the number and prevalence of patients aged 18 and over on the Quality and Outcomes Framework (QOF) depression register in England, as at 31 March for the years 2010/11-2014/15 is shown in the table below.

Data on anxiety is not collected through QOF.

Year	Number of general practitioner (GP) practices	Patient list size all ages	Percentage aged 18 and over	Estimated patient list size of those aged 18 and over	Number of patients aged 18 and over on the depression register	Prevalance
2014/15 2013/14 2012/13 2011/12 2010/11	7,779 7,921 8,020 8,123 8,245	55,817,654 56,324,887 56,012,096 55,525,732 55,169,643	79.3 79.3 79.0 79.0 79.0	45,083,980 44,667,478 44,238,483 43,855,136 43,578,391	3,305,363 2,912,592 2,582,233 5,123,948 4,878,188	7.3 6.5 5.8 11.7 11.2

Source: Quality and Outcomes Framework annual publications, 2010/11 to 2014/15

Note:

Data from years prior to 2012/13 are not comparable with data for years 2012/13 onwards as the QOF business rules for including patients on the depression register changed in 2012/13. Prior to 2012/13, all patients with a record of unresolved depression at any point in their GP patient record were included on the register. As of 1 April 2012, the register rules were changed to only include patients with a new diagnosis of depression in the preceding 1 April to 31 March, who have had a bio-psychosocial assessment by the point of diagnosis.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, what discussions he has had with the Royal College of Nursing on steps to reduce the fat intake of people with diabetes.

Jane Ellison

There have been no such recent discussions.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, how many people there were with epilepsy in each of the last five years.

Jane Ellison

Information concerning the number of people diagnosed with epilepsy on an annual basis is not collected. The National Institute for Health and Care Excellence estimates that epilepsy affects between 362,000 and 415,000 people in England.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, what plans he has to make the Attiva device for the treatment of people with diabetes available on the NHS.

George Freeman

Medical devices are required to be CE marked under the European Union medical devices Directives and may not be placed on the market until this process is complete.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, what plans he has to provide paramedics with on-the-spot blood diagnostic devices for the detection of medical conditions.

Jane Ellison

The provision of medical equipment for front-line ambulance service staff falls within the responsibility of individual ambulance trusts. Paramedics already do have access to, and routinely carry, some blood-testing devices for example, to check for blood sugar.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Minister for the Cabinet Office, how many children have died due to accidents related to blind cords in each of the last five years.

Mr Rob Wilson

The information requested falls within the responsibility of the UK Statistics Authority. I have asked the Authority to reply.

The below Parliamentary question was asked by Jim Shannon on 2016-01-12.

To ask the Secretary of State for Health, what assessment he has made of the effect of the negative interim NICE Appraisal Committee Decision on nivolumab for squamous non-small cell lung cancer on patients.

George Freeman

No such assessment has been made. The National Institute for Health and Care Excellence (NICE) is currently appraising nivolumab (Opdivo) for squamous non-small cell lung cancer and has not yet issued its final guidance.

In developing its technology appraisal guidance, NICE works closely with stakeholders, including manufacturers. NICE’s consultation on its draft guidance closed on 19 January 2016.

In the absence of NICE guidance, it is for commissioners to make funding decisions based on the available evidence.